NBI 30545
NBI 30545 is a blood-brain barrier permeable CRF1R antagonist with a Ki value of 3.4 nM for the human receptor. NBI 30545 inhibits CRF-stimulated intracellular cAMP accumulation and ACTH release. NBI 30545 can be used in the research of depression, anxiety disorders and stress-related diseases.
For research use only. We do not sell to patients.
- CAS No.: 195054-99-0
- Formula: C22H30N4O3
- Molecular Weight:398.51
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | IC50 |
76 nM
Compound: 8
|
Inhibition of [125I]o-CRF binding to CHO cells expressing human CRF1 receptor
Inhibition of [125I]o-CRF binding to CHO cells expressing human CRF1 receptor
|
[PMID: 15341493] |
| Pituitary gland cell | IC50 |
37 nM
Compound: 18n
|
Inhibition of CRF-stimulated ACTH release in cultured rat anterior pituitary cells
Inhibition of CRF-stimulated ACTH release in cultured rat anterior pituitary cells
|
[PMID: 15203140] |
| Pituitary gland cell | IC50 |
76 nM
Compound: 18n
|
Inhibition of CRF-stimulated cAMP production in cultured rat anterior pituitary cells
Inhibition of CRF-stimulated cAMP production in cultured rat anterior pituitary cells
|
[PMID: 15203140] |
NBI 30545 inhibits CRF-stimulated cAMP accumulation in cells expressing the human CRF1 receptor with an IC50 of 76 nM[1].
NBI 30545 inhibits CRF-stimulated ACTH release in cultured rat anterior pituitary cells with an IC50 of 37 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley[1]
-
Dosage:10 mg/kg (i.v.); 10 mg/kg (p.o.)
-
Administration:i.v.; single dose; p.o.; single dose
-
Result:Achieved a volume of distribution of 4.7 L/kg, clearance of 43 mL/min/kg, and a half-life of 1.1 h after intravenous administration.
Reached a plasma AUC of 1182 ng/mL·h, brain AUC of 1472 ng/g·h, oral bioavailability of 30.5%, and a brain/plasma ratio of 1.2 after oral administration.
Chemical Information
-
CAS No. 195054-99-0
-
Molecular Weight 398.51
-
Formula C22H30N4O3
-
SMILES
N1=C(C=C(N2N=C(C(=C12)C=3C=CC(OC)=CC3OC)C)N(CCOC)CCC)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)